All Articles
How Americord Ensures Safety with Backup Systems
Explains multi-layer protections for cord blood: nitrogen cryostorage at −196°C, UPS/generator backups, 24/7 monitoring, GenVault disaster recovery, and data redundancy.
Emergency Preparedness: Why Bank Stem Cells
Bank newborn cord blood and tissue to preserve stem cells that can treat 80+ conditions, shorten donor searches, and provide faster access to therapy.
Future of MS Treatment with Stem Cells
Overview of stem cell approaches for MS—HSCT, MSCs, perinatal cells, and exosomes—clinical trial outcomes, safety and newborn stem cell banking options.
Umbilical Cord Blood in Rare Disease Treatment
How cord blood stem cells treat rare genetic disorders, improve survival and neurological outcomes, and why banking at birth offers timely access to transplants.
Mesenchymal Stem Cells for Crohn's Fistulas: Research Update
MSC therapies for Crohn's fistulas show ~58% remission at 6 months; adipose and cord-derived cells are promising and generally well tolerated.
Clinical Trials for Stem Cell Disc Repair
Examines clinical trials of stem cell treatments for degenerative disc disease, reporting structural regeneration, pain outcomes, safety, and emerging delivery and cell-free therapies.
Advances in Muscle Regeneration Using Cord Blood
Umbilical cord blood and exosomes reduce inflammation, activate satellite cells, and help restore muscle mass and function after aging or injury.
Future of Cord Blood in Regenerative Therapy
A concise overview of cord blood’s role in regenerative medicine, current uses, advances in cell expansion and gene editing, and challenges for banking and access.
Regulatory Standards for Data Security in Stem Cell Banking
Compare HIPAA, FDA and GDPR rules for protecting genetic and health data in stem cell banks, covering encryption, breach reporting and data retention conflicts.